Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BY-NCCancer medicine

Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers

  • Mobina Darabi1
  • Zeynab Zahedi1
  • Kosar Zolfaghari1
  • Alireza Kordi1
  • Kiarash Saleki2
  • Niloufar Yazdanpanah2
  • Nima Rezaei2
  1. 1Universal Scientific Education and Research Network (USERN)
  2. 2Tehran University of Medical Sciences
Read full textPDFCite

Related

  1. Fc-Dependent Targeting of the GAS6-MERTK Axis With Monoclonal and Bispecific Antibodies Overcomes Drug Resistance Across EGFR Mutations in Exons 19, 20, and 21.
    Suvendu Giri, Boobash Raj Selvadurai, Nitin Gupta +26
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Novel monoclonal antibodies for an activated protein C cleavage neoepitope of coagulation factor Va
    Research and practice in thrombosis and haemostasisPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases
    Abdorreza Naser Moghadasi, Sreeram Ramagopalan, Simona Bonavita +1
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossref
  4. 83 Translational PBPK modeling of PET imaging reveals enhanced predicted tumor exposure of antiCTLA4 singledomain antibody fragments vs. monoclonal antibodies
    Kapil Mayawala, Edward Bowman, Xiangjun Meng +10
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textMedical imaging & radiologyDOAJ
  5. Anti-Nectin4 monoclonal antibodies attenuate airway inflammation and epithelial barrier dysfunction in asthma
    Pureun-Haneul Lee, MinHyeok An, SangMin Yoon +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPhysiologyCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@article{darabi2026targeting,
  title = {{Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers}},
  author = {Mobina Darabi and Zeynab Zahedi and Kosar Zolfaghari and Alireza Kordi and Kiarash Saleki and Niloufar Yazdanpanah and Nima Rezaei},
  journal = {Cancer medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658938},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers
AU  - Mobina Darabi
AU  - Zeynab Zahedi
AU  - Kosar Zolfaghari
AU  - Alireza Kordi
AU  - Kiarash Saleki
AU  - Niloufar Yazdanpanah
AU  - Nima Rezaei
PY  - 2026
DA  - 2026/10/01
JO  - Cancer medicine
UR  - https://europepmc.org/article/PMC/PMC13658938
SN  - 2045-7634
ER  -